ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix, Inc. today announced that data demonstrating the utility of the Rheonix CARD™ (Chemistry And Reagent Device) system for human in vitro diagnostic purposes will be presented in poster sessions at the American Association for Clinical Chemistry (AACC) Annual Meeting being held in Anaheim, CA, July 25-29, 2010. Rheonix will also exhibit at the Clinical Lab Expo, Booth #1432.
